Delpharm Lille

Delpharm Lille is a specialized pharmaceutical manufacturing facility located in Lys-lez-Lannoy, France, and is a key site within the Delpharm group, a leading European Contract Development and Manufacturing Organization (CDMO). The site is particularly recognized for its expertise in the production of hormonal drug products, including oral solid and liquid dosage forms. Originally acquired from Bayer in 2006, the facility provides comprehensive services ranging from formulation development and pilot-scale production to high-volume commercial manufacturing and global packaging. It operates under strict GMP standards and serves a diverse client base of international pharmaceutical companies, supporting products distributed in over 100 countries. The site plays a critical role in the group's technical capabilities for handling high-potency compounds and complex hormonal treatments.